Sign up for a free trial now
  • Login
  • Subscribe
  • Take a FREE Trial
  • About Us
  • Contact us
  • RSS

19 June 2013


The Pharma Letter
  • Home
  • 7 Day Premium Trial
  • Pharmaceuticals
  • Biotechnology
  • Generics
  • Events
  • Companies
  • Drugs
  • Subscribe

Mysoline Articles

Sinclair IS Pharma divests Mysoline to Lab SERB for £11 million

15 November 2011

Elan's top 10 product line sales up 70% in 1st qtr, but results disappoint

13 May 2002

Strong earnings growth for Ireland's Elan on healthy US sales

11 February 2002

Elan and Vernalis antimigraine drug wins US approval

12 November 2001

Ireland's Elan posts strong revenue rise, buys pain products from Boeh

29 October 2001

Elan Corp posts 25% increase in 2nd-qtr revenues as EPS climbs 45%

24 July 2001

Elan net income leaps 89% in 1st qtr

24 April 2001

Elan full-year 2000 sales top $1.50 billion

29 January 2001

Liposome and Segix boost Elan revenues

21 July 2000

Elan Corp gains approval of Zonegran in USA for epilepsy

29 March 2000

Draxis Health markets Mysoline in Canada

2 March 2000

Hefty increase in 3rd qtr revenues at Elan

26 October 1999

Revenues Rise 63% At Ireland's Elan Corp In Third Quarter

27 October 1998

Elan's 2nd Qtr Revenues Leap 82%

30 July 1998

Elan Posts Record Growth In 1st Quarter 1998

27 April 1998

Elan's Zonisamide Nears US Approval

25 March 1998

Elan To Acquire Wyeth's Mysoline

19 February 1998

Russian Drugs: "Never Mind The Project, Buy The Guy"

9 June 1997

ABPI Highlights Advances In Epilepsy Treatment

6 May 1996

Encouraging Results With Tiagabine

9 January 1995

POLFA AND HOECHST DEAL

21 December 1992

Showing 1-21 of 21 articles

Go to beginningPrevious
  • 1
NextGo to end
  • Hot Topics
  • Most Read
  • InSite Vision joins Merck & Co and Pfizer in patent infringement law suit against
  • Osteoporosis drug bazedoxifene stops growth of breast cancer cells, even in resistant tumors
  • Highlights of EHA meeting: Novartis' Jakavi; Bristol-Myers and AbbVie's elotuzumab; Janssen's ibrutinib
  • Additional indications in Japan for Roche's Avastin and Astellas' Prograf
  • US Supreme Court says patent settlement can "sometimes" be illegal
  • InSite Vision joins Merck & Co and Pfizer in patent infringement law suit against
  • Osteoporosis drug bazedoxifene stops growth of breast cancer cells, even in resistant tumors
  • Highlights of EHA meeting: Novartis' Jakavi; Bristol-Myers and AbbVie's elotuzumab; Janssen's ibrutinib
  • Additional indications in Japan for Roche's Avastin and Astellas' Prograf
  • US Supreme Court says patent settlement can "sometimes" be illegal

30 Day Premium Trial


Events

Twitter Right banner

RSS



© 2013 thepharmaletter.com

  • Home
  • RSS
  • About Us
  • Subscribe
  • Terms and Conditions
  • Article Archive
Site powered by WORKSsitebuilder CMS